All posts by: Michael Zand

About Michael Zand

Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia – AJMC.com Managed Markets Network

Continue reading

2017-10-20 NEWS

Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia
AJMC.com Managed Markets Network
CD19 CAR T cells are highly effective in high-risk patients with chronic lymphocytic leukemia (CLL) who have failed to respond to treatment with ibrutinib, a Bruton’s tyrosine kinase inhibitor, according to a study by Cameron J. Turtle, MD, and …

and more »

Continue reading

2017-10-20 NEWS

ModernMedicine

Game-changing gene therapies present cost problems for health execs
ModernMedicine
The recent approval of two cell-based gene therapies has healthcare executives scratching their heads about ways to manage these anticipated costly drugs, say experts. In August, the FDA approved Novartis’s tisagenlecleucel (Kymriah), the first …

and more »